Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-05-16 Sale |
2024-05-20 8:02 pm |
Replimune Group Inc. | REPL | Coffin Robert Director |
11,464 | $6.47 | $74,172 | 1,821,872 (Direct) |
View |
2023-05-16 Sale |
2023-05-18 8:35 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
7,861 | $18.05 | $141,891 | 1,833,336 (Direct) |
View |
2022-05-16 Sale |
2022-05-18 7:01 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
5,737 | $14.59 | $83,703 | 1,796,197 (Direct) |
View |
2021-07-02 Sale |
2021-07-07 9:01 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
7,810 | $40.04 | $312,712 | 1,775,684 (Direct) |
View |
2021-06-28 Sale |
2021-06-30 9:00 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
37,489 | $40.05 | $1,501,288 | 1,783,494 (Direct) |
View |
2021-01-22 Sale |
2021-01-26 9:00 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
60,000 | $44.43 | $2,665,973 | 1,744,118 (Direct) |
View |
2020-12-22 Sale |
2020-12-28 9:03 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
220,000 | $40.04 | $8,808,800 | 1,804,118 (Direct) |
View |
2020-07-09 Sale |
2020-07-10 9:00 pm |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
169,750 | $22.13 | $3,757,295 | 2,024,118 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-01 Option Award |
2023-04-04 8:00 pm |
N/A 2033-04-01 |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
112,500 | $0 | 1,908,697 (Direct) |
View |
2022-04-01 Option Award |
2022-04-05 4:18 pm |
N/A 2032-04-01 |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
65,625 | $0 | 1,841,309 (Direct) |
View |
2021-04-01 Option Award |
2021-04-05 8:18 pm |
N/A 2031-04-01 |
Replimune Group Inc. | REPL | Coffin Robert President & Chief R&D Officer |
192,165 | $0 | 1,936,283 (Direct) |
View |